Cargando…
Eosinophilic Granulomatosis with Polyangiitis Presenting with Central Retinal Artery Occlusion During Treatment with Anti-interleukin-5 Receptor Monoclonal Antibody
Eosinophilic granulomatosis with polyangiitis (EGPA) is an anti-neutrophilic cytoplasm antibody (ANCA)-associated vasculitis characterized by asthma and eosinophilia. Although EGPA involves multiple organs, ocular involvement is infrequent and often carries a poor visual prognosis. We herein report...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666228/ https://www.ncbi.nlm.nih.gov/pubmed/34092731 http://dx.doi.org/10.2169/internalmedicine.7027-21 |
_version_ | 1784614162102484992 |
---|---|
author | Nishiyama, Hirono Tajiri, Tomoko Yamabe, Toru Yasukawa, Tsutomu Takeda, Norihisa Fukumitsu, Kensuke Fukuda, Satoshi Kanemitsu, Yoshihiro Uemura, Takehiro Ohkubo, Hirotsugu Takemura, Masaya Maeno, Ken Ito, Yutaka Oguri, Tetsuya Naniwa, Taio Niimi, Akio |
author_facet | Nishiyama, Hirono Tajiri, Tomoko Yamabe, Toru Yasukawa, Tsutomu Takeda, Norihisa Fukumitsu, Kensuke Fukuda, Satoshi Kanemitsu, Yoshihiro Uemura, Takehiro Ohkubo, Hirotsugu Takemura, Masaya Maeno, Ken Ito, Yutaka Oguri, Tetsuya Naniwa, Taio Niimi, Akio |
author_sort | Nishiyama, Hirono |
collection | PubMed |
description | Eosinophilic granulomatosis with polyangiitis (EGPA) is an anti-neutrophilic cytoplasm antibody (ANCA)-associated vasculitis characterized by asthma and eosinophilia. Although EGPA involves multiple organs, ocular involvement is infrequent and often carries a poor visual prognosis. We herein report a rare case of EGPA presenting with central retinal artery occlusion (CRAO) in which visual loss developed during treatment with anti-interleukin (IL)-5 receptor monoclonal antibody, and improvement in visual outcomes was attained after treatment combining high-dose oral corticosteroids, cyclophosphamide and an anticoagulant. Physicians should consider CRAO as an ophthalmic manifestation of EGPA in patients with severe eosinophilic asthma. |
format | Online Article Text |
id | pubmed-8666228 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Japanese Society of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-86662282021-12-28 Eosinophilic Granulomatosis with Polyangiitis Presenting with Central Retinal Artery Occlusion During Treatment with Anti-interleukin-5 Receptor Monoclonal Antibody Nishiyama, Hirono Tajiri, Tomoko Yamabe, Toru Yasukawa, Tsutomu Takeda, Norihisa Fukumitsu, Kensuke Fukuda, Satoshi Kanemitsu, Yoshihiro Uemura, Takehiro Ohkubo, Hirotsugu Takemura, Masaya Maeno, Ken Ito, Yutaka Oguri, Tetsuya Naniwa, Taio Niimi, Akio Intern Med Case Report Eosinophilic granulomatosis with polyangiitis (EGPA) is an anti-neutrophilic cytoplasm antibody (ANCA)-associated vasculitis characterized by asthma and eosinophilia. Although EGPA involves multiple organs, ocular involvement is infrequent and often carries a poor visual prognosis. We herein report a rare case of EGPA presenting with central retinal artery occlusion (CRAO) in which visual loss developed during treatment with anti-interleukin (IL)-5 receptor monoclonal antibody, and improvement in visual outcomes was attained after treatment combining high-dose oral corticosteroids, cyclophosphamide and an anticoagulant. Physicians should consider CRAO as an ophthalmic manifestation of EGPA in patients with severe eosinophilic asthma. The Japanese Society of Internal Medicine 2021-06-05 2021-11-15 /pmc/articles/PMC8666228/ /pubmed/34092731 http://dx.doi.org/10.2169/internalmedicine.7027-21 Text en Copyright © 2021 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Nishiyama, Hirono Tajiri, Tomoko Yamabe, Toru Yasukawa, Tsutomu Takeda, Norihisa Fukumitsu, Kensuke Fukuda, Satoshi Kanemitsu, Yoshihiro Uemura, Takehiro Ohkubo, Hirotsugu Takemura, Masaya Maeno, Ken Ito, Yutaka Oguri, Tetsuya Naniwa, Taio Niimi, Akio Eosinophilic Granulomatosis with Polyangiitis Presenting with Central Retinal Artery Occlusion During Treatment with Anti-interleukin-5 Receptor Monoclonal Antibody |
title | Eosinophilic Granulomatosis with Polyangiitis Presenting with Central Retinal Artery Occlusion During Treatment with Anti-interleukin-5 Receptor Monoclonal Antibody |
title_full | Eosinophilic Granulomatosis with Polyangiitis Presenting with Central Retinal Artery Occlusion During Treatment with Anti-interleukin-5 Receptor Monoclonal Antibody |
title_fullStr | Eosinophilic Granulomatosis with Polyangiitis Presenting with Central Retinal Artery Occlusion During Treatment with Anti-interleukin-5 Receptor Monoclonal Antibody |
title_full_unstemmed | Eosinophilic Granulomatosis with Polyangiitis Presenting with Central Retinal Artery Occlusion During Treatment with Anti-interleukin-5 Receptor Monoclonal Antibody |
title_short | Eosinophilic Granulomatosis with Polyangiitis Presenting with Central Retinal Artery Occlusion During Treatment with Anti-interleukin-5 Receptor Monoclonal Antibody |
title_sort | eosinophilic granulomatosis with polyangiitis presenting with central retinal artery occlusion during treatment with anti-interleukin-5 receptor monoclonal antibody |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666228/ https://www.ncbi.nlm.nih.gov/pubmed/34092731 http://dx.doi.org/10.2169/internalmedicine.7027-21 |
work_keys_str_mv | AT nishiyamahirono eosinophilicgranulomatosiswithpolyangiitispresentingwithcentralretinalarteryocclusionduringtreatmentwithantiinterleukin5receptormonoclonalantibody AT tajiritomoko eosinophilicgranulomatosiswithpolyangiitispresentingwithcentralretinalarteryocclusionduringtreatmentwithantiinterleukin5receptormonoclonalantibody AT yamabetoru eosinophilicgranulomatosiswithpolyangiitispresentingwithcentralretinalarteryocclusionduringtreatmentwithantiinterleukin5receptormonoclonalantibody AT yasukawatsutomu eosinophilicgranulomatosiswithpolyangiitispresentingwithcentralretinalarteryocclusionduringtreatmentwithantiinterleukin5receptormonoclonalantibody AT takedanorihisa eosinophilicgranulomatosiswithpolyangiitispresentingwithcentralretinalarteryocclusionduringtreatmentwithantiinterleukin5receptormonoclonalantibody AT fukumitsukensuke eosinophilicgranulomatosiswithpolyangiitispresentingwithcentralretinalarteryocclusionduringtreatmentwithantiinterleukin5receptormonoclonalantibody AT fukudasatoshi eosinophilicgranulomatosiswithpolyangiitispresentingwithcentralretinalarteryocclusionduringtreatmentwithantiinterleukin5receptormonoclonalantibody AT kanemitsuyoshihiro eosinophilicgranulomatosiswithpolyangiitispresentingwithcentralretinalarteryocclusionduringtreatmentwithantiinterleukin5receptormonoclonalantibody AT uemuratakehiro eosinophilicgranulomatosiswithpolyangiitispresentingwithcentralretinalarteryocclusionduringtreatmentwithantiinterleukin5receptormonoclonalantibody AT ohkubohirotsugu eosinophilicgranulomatosiswithpolyangiitispresentingwithcentralretinalarteryocclusionduringtreatmentwithantiinterleukin5receptormonoclonalantibody AT takemuramasaya eosinophilicgranulomatosiswithpolyangiitispresentingwithcentralretinalarteryocclusionduringtreatmentwithantiinterleukin5receptormonoclonalantibody AT maenoken eosinophilicgranulomatosiswithpolyangiitispresentingwithcentralretinalarteryocclusionduringtreatmentwithantiinterleukin5receptormonoclonalantibody AT itoyutaka eosinophilicgranulomatosiswithpolyangiitispresentingwithcentralretinalarteryocclusionduringtreatmentwithantiinterleukin5receptormonoclonalantibody AT oguritetsuya eosinophilicgranulomatosiswithpolyangiitispresentingwithcentralretinalarteryocclusionduringtreatmentwithantiinterleukin5receptormonoclonalantibody AT naniwataio eosinophilicgranulomatosiswithpolyangiitispresentingwithcentralretinalarteryocclusionduringtreatmentwithantiinterleukin5receptormonoclonalantibody AT niimiakio eosinophilicgranulomatosiswithpolyangiitispresentingwithcentralretinalarteryocclusionduringtreatmentwithantiinterleukin5receptormonoclonalantibody |